查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585659

生醫光電市場：按應用、最終用途分類 - 2025-2030 年全球預測

Biophotonics Market by Application (Biosensors, Inside Imaging, Light Therapy), End-Use (Medical Diagnostics, Medical Therapeutics, Non-Medical Application) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年生醫光電市值為579.1億美元，預計到2024年將達到631.4億美元，複合年成長率為9.12%，到2030年將達到1067.1億美元。

生醫光電是一個跨學科領域，它將基於光的技術應用於生物材料的研究。這包括開發和使用光子裝置和技術，用於在分子和細胞層面分析、成像和操縱生物組織。對光電的需求源自於其提供非侵入性、高解析度、高精度診斷和治療解決方案的能力，大大推進了醫學研究、診斷和治療。主要應用包括光學同調斷層掃瞄、顯微鏡和光譜學等成像系統，它們在早期疾病檢測、個人化醫療和微創治療中發揮關鍵作用。主要的最終用途領域是醫療、製藥、生物技術和環境監測，由於對先進診斷程序和治療的需求不斷成長，醫療成為主要驅動力。

主要市場統計
基準年[2023] 579.1億美元
預測年份 [2024] 631.4億美元
預測年份 [2030] 1067.1億美元
複合年成長率（%） 9.12%

市場成長是由技術進步、政府研究經費增加以及對早期疾病檢測技術的認知不斷提高所推動的。慢性病的增加和世界人口的老化進一步增加了對創新診斷和治療解決方案的需求。最近的全球健康危機凸顯了對非接觸式醫療保健解決方案的需求，在擴大遠端醫療和遠距離診斷的使用方面存在潛在機會。然而，昂貴的設備、複雜的監管要求以及缺乏熟練專業人員等挑戰構成了重大障礙。此外，快速的技術進步需要不斷的研發投資，這可能會對中小企業的商業資源造成壓力。

生醫光電的創新可以針對具有成本效益的可攜式診斷工具，並與人工智慧整合，以增強資料分析和預測診斷。奈米級成像和微創光學生物感測器也應被視為潛在的成長領域。學術界和工業界的合作可以加速技術進步。市場格局充滿活力且快速成長，其特點是密集的研發活動和不斷發展的技術範式。公司可以透過投資新技術、促進跨學科合作以及根據醫療保健提供者和患者的特定需求量身定做解決方案來保持競爭力。

市場動態：揭示快速發展的生醫光電市場的關鍵市場洞察

供需的動態交互作用正在改變生醫光電市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 老年人口增加
    • 新型光聲斷層掃描（PAT）系統的開發
    • 生醫光電應用於細胞/組織診斷
  • 市場限制因素
    • 不願意採用新的治療方法
  • 市場機會
    • 生醫光電在非醫療領域的應用
    • 奈米科技的出現
  • 市場問題
    • 對生醫光電技術缺乏認知

波特五力：駕馭生醫光電市場的策略工具

波特的五力框架是了解生醫光電市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生醫光電市場的外部影響

外部宏觀環境因素在塑造生醫光電市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解生醫光電市場的競爭格局

對生醫光電市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣生醫光電市場供應商的績效評估

FPNV定位矩陣是評估生醫光電市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製生醫光電市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對生醫光電市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 老年人口增加
      • 新型光聲成像（PAT）系統的開發
      • 生醫光電在細胞和組織診斷的應用
    • 抑制因素
      • 抵制引入新治療方法
    • 機會
      • 生醫光電在醫療領域以外的應用
      • 奈米科技的出現
    • 任務
      • 對生醫光電技術缺乏認知
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章生醫光電市場：依應用分類

  • 介紹
  • 生物感測器
  • 內部影像
  • 光療
  • 顯微鏡檢查
  • 透視成像
  • 光譜分子
  • 表面成像

第7章生醫光電市場：依最終用途

  • 介紹
  • 醫學診斷
  • 醫療
  • 非醫療用途
  • 測試和組件

第8章北美和南美生醫光電市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太生醫光電市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的生醫光電市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Becton, Dickinson and Company
  • Carl Zeiss AG
  • Hamamatsu Photonics KK
  • Idex Corporation
  • ImpediMed Limited
  • Lumenis Be Ltd.
  • LUMICKS Technologies BV
  • Magritek
  • Olympus Corporation
  • Oxford Instruments Group
  • PerkinElmer Inc.
  • Photopharmics, Inc.
  • Thermo Fisher Scientific Inc.
  • THINKCYTE Inc.
  • VivoSight by Michelson Diagnostics Ltd.
Product Code: MRR-437D45957BF6

The Biophotonics Market was valued at USD 57.91 billion in 2023, expected to reach USD 63.14 billion in 2024, and is projected to grow at a CAGR of 9.12%, to USD 106.71 billion by 2030.

Biophotonics is an interdisciplinary field that involves the application of light-based technologies to study biological materials. It encompasses the development and use of photonic devices and techniques to analyze, image, and manipulate living tissues at the molecular and cellular levels. The necessity of biophotonics arises from its capability to provide non-invasive, high-resolution, and precise diagnostic and therapeutic solutions, significantly advancing medical research, diagnostics, and treatment. The primary applications include imaging systems like optical coherence tomography, microscopy, and spectroscopy, which play crucial roles in early disease detection, personalized medicine, and minimally invasive treatments. Key end-use sectors are healthcare, pharmaceuticals, biotechnology, and environmental monitoring, with healthcare being the principal driver due to rising demands for advanced diagnostic procedures and treatments.

KEY MARKET STATISTICS
Base Year [2023] USD 57.91 billion
Estimated Year [2024] USD 63.14 billion
Forecast Year [2030] USD 106.71 billion
CAGR (%) 9.12%

In terms of market growth, biophotonics is influenced by technological advancements, increasing government funding for research, and heightened awareness of early disease detection techniques. The rise in chronic diseases and the aging global population further fuel the demand for innovative diagnostic and therapeutic solutions. Potential opportunities lie in expanding applications for telemedicine and remote diagnostics, driven by recent global health crises emphasizing the need for contactless healthcare solutions. However, challenges such as high costs of equipment, complex regulatory requirements, and lack of skilled professionals pose significant roadblocks. Additionally, rapid technological evolution necessitates constant investment in R&D, which may strain resources for smaller players.

Innovation in biophotonics can be directed towards cost-effective, portable diagnostic tools, and integration with artificial intelligence for enhanced data analysis and predictive diagnostics. Businesses should also explore nanoscale imaging and minimally invasive optical biosensors as potential growth areas. Collaborations between academia and industry could expedite technological advancements. The biophotonics market presents a dynamic and rapidly growing landscape, characterized by intense R&D activities and evolving technological paradigms. Companies can maintain a competitive edge by investing in emerging technologies, fostering cross-disciplinary collaborations, and tailoring solutions to meet the specific needs of healthcare providers and patients.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biophotonics Market

The Biophotonics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in geriatric populations
    • Development of novel Photoacoustic Tomography (PAT) System
    • Adoption biophotonics in cell and tissue diagnostics
  • Market Restraints
    • Reluctance toward the adoption of new treatment practices
  • Market Opportunities
    • Use of biophotonics in non-medical sectors
    • Emergence of nanotechnology
  • Market Challenges
    • Lack of awareness of biophotonics technology

Porter's Five Forces: A Strategic Tool for Navigating the Biophotonics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biophotonics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biophotonics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biophotonics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biophotonics Market

A detailed market share analysis in the Biophotonics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biophotonics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biophotonics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biophotonics Market

A strategic analysis of the Biophotonics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biophotonics Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Carl Zeiss AG, Hamamatsu Photonics K.K., Idex Corporation, ImpediMed Limited, Lumenis Be Ltd., LUMICKS Technologies B.V., Magritek, Olympus Corporation, Oxford Instruments Group, PerkinElmer Inc., Photopharmics, Inc., Thermo Fisher Scientific Inc., THINKCYTE Inc., and VivoSight by Michelson Diagnostics Ltd..

Market Segmentation & Coverage

This research report categorizes the Biophotonics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Biosensors, Inside Imaging, Light Therapy, Microscopy, See-Through Imaging, Spectro Molecular, and Surface Imaging.
  • Based on End-Use, market is studied across Medical Diagnostics, Medical Therapeutics, Non-Medical Application, and Tests & Components.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in geriatric populations
      • 5.1.1.2. Development of novel Photoacoustic Tomography (PAT) System
      • 5.1.1.3. Adoption biophotonics in cell and tissue diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Reluctance toward the adoption of new treatment practices
    • 5.1.3. Opportunities
      • 5.1.3.1. Use of biophotonics in non-medical sectors
      • 5.1.3.2. Emergence of nanotechnology
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness of biophotonics technology
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biophotonics Market, by Application

  • 6.1. Introduction
  • 6.2. Biosensors
  • 6.3. Inside Imaging
  • 6.4. Light Therapy
  • 6.5. Microscopy
  • 6.6. See-Through Imaging
  • 6.7. Spectro Molecular
  • 6.8. Surface Imaging

7. Biophotonics Market, by End-Use

  • 7.1. Introduction
  • 7.2. Medical Diagnostics
  • 7.3. Medical Therapeutics
  • 7.4. Non-Medical Application
  • 7.5. Tests & Components

8. Americas Biophotonics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biophotonics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biophotonics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Becton, Dickinson and Company
  • 2. Carl Zeiss AG
  • 3. Hamamatsu Photonics K.K.
  • 4. Idex Corporation
  • 5. ImpediMed Limited
  • 6. Lumenis Be Ltd.
  • 7. LUMICKS Technologies B.V.
  • 8. Magritek
  • 9. Olympus Corporation
  • 10. Oxford Instruments Group
  • 11. PerkinElmer Inc.
  • 12. Photopharmics, Inc.
  • 13. Thermo Fisher Scientific Inc.
  • 14. THINKCYTE Inc.
  • 15. VivoSight by Michelson Diagnostics Ltd.

LIST OF FIGURES

  • FIGURE 1. BIOPHOTONICS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHOTONICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHOTONICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHOTONICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHOTONICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPHOTONICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOPHOTONICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOPHOTONICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOPHOTONICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOPHOTONICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHOTONICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHOTONICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHOTONICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHOTONICS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHOTONICS MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHOTONICS MARKET SIZE, BY INSIDE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHOTONICS MARKET SIZE, BY LIGHT THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHOTONICS MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHOTONICS MARKET SIZE, BY SEE-THROUGH IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHOTONICS MARKET SIZE, BY SPECTRO MOLECULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHOTONICS MARKET SIZE, BY SURFACE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHOTONICS MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHOTONICS MARKET SIZE, BY MEDICAL THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHOTONICS MARKET SIZE, BY NON-MEDICAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHOTONICS MARKET SIZE, BY TESTS & COMPONENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES BIOPHOTONICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. BIOPHOTONICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 107. BIOPHOTONICS MARKET, FPNV POSITIONING MATRIX, 2023